Research Article

SARS-CoV-2-Specific T Cell Immunity in HIV-Associated Kaposi Sarcoma Patients in Zambia

Figure 2

SARS-CoV-2-specific T cell responses by CD4 counts. (a) SARS-CoV-2-specific T cell responses against Spike S1 subunit and NMO peptide pools by CD4 count categories at baseline. (b) SARS-CoV-2-specific T cell responses against Spike S1 subunit and NMO peptide pools by CD4 count categories at follow-up.
(a)
(b)